Siren, L.L.C. Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0002005245
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q1 2026 · 100 positions · Total reported value $3.61B · Top-10 concentration 49.8% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 55.7% · 15 new · 36 cut · 22 exited
Active Share (vs S&P 500): 97.6% · vs QQQ: 97.6% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q2 2026 → Q3 2026): -13.5% · vs SPY -15.6% · Prev Value $4.93B — last quarter positions weighted by this quarter price moves · ranking
Est. QTD Return (Q3 2026 → newest close): -4.2% · vs SPY -6.4% · Latest Value $4.21B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking
In its Q1 2026 13F filing, Siren, L.L.C. disclosed 100 equity positions with a combined reported value of $3.61B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 49.8% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.
The largest disclosed positions as of Q1 2026 were SRRK ($532.16M), KYMR ($265.43M), ERAS ($181.93M). By sector, the heaviest allocations are Health Care 90.4%, Technology 4.7%. Versus the prior quarter, allocation shifted toward Health Care (+6.4pp) and away from Communication Services (-0.5pp), Other (-5.7pp).
Versus the prior quarter, Siren, L.L.C. opened 15 new positions, trimmed 36 and fully exited 22, a turnover rate of 55.7% of positions. The portfolio's overlap with the prior quarter was 61% of names.
The largest new positions opened in Q1 2026 were MANE ($95.06M), CYTK ($40.47M), ELVN ($29.25M).
Of the 22 positions fully exited versus the prior quarter, the largest were APLS ($64.77M), ASND ($50.30M), RAPT ($46.57M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q1 2026)
- MANE Veradermics, Incorporated · $95.06M
- CYTK Cytokinetics, Incorporated · $40.47M
- ELVN Enliven Therapeutics, Inc. · $29.25M
- DMRA Damora Therapeutics Inc · $23.31M
- ANNX Annexon, Inc. · $21.93M
- DFTX DEFINIUM THERAPEUTICS INC · $17.38M
- AMLX Amylyx Pharmaceuticals, Inc. · $17.10M
- QURE UNIQURE NV · $16.35M
Fully Exited (vs previous quarter)
- APLS APELLIS PHARMACEUTICALS INC · prev qtr: $64.77M
- ASND ASCENDIS PHARMA A/S · prev qtr: $50.30M · history
- RAPT RAPT THERAPEUTICS INC · prev qtr: $46.57M
- ZYME ZYMEWORKS INC · prev qtr: $44.24M
- MLYS MINERALYS THERAPEUTICS INC · prev qtr: $25.40M
- IHS IHS HOLDING LIMITED · prev qtr: $17.59M
- UPB UPSTREAM BIO INC COM · prev qtr: $15.98M
- MNMD MIND MEDICINE MINDMED INC · prev qtr: $10.71M
Insider Transactions (Form 4)
Latest Siren, L.L.C. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Siren, L.L.C. files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 116 positions worth $4.93B in total. HoldingsHub carries 8 quarters of its filings (Q3 2024–Q2 2026).
Portfolio Structure
- 116 positions · $4.93B reported value (Q2 2026)
- Top 10 holdings = 44.8% of reported value
- Largest position: SRRK (SCHOLAR ROCK HLDG CORP) at 10.7%
- Average position size: $42.48M
Sector Tilt
- Health Care 92.0%
- Information Technology 4.5%
- Consumer Discretionary 1.2%
- (classified holdings cover 99% of value)
Quarterly Activity
- Q2 2026: 25 new, 32 added, 21 reduced, 9 exited
- 38 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
Sector Allocation
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
10.83M | $532.16M | 14.75% | Hold | |
| 2 |
|
3.19M | $265.43M | 7.36% | Reduce | |
| 3 |
|
11.24M | $181.93M | 5.04% | Add | |
| 4 |
|
4.43M | $139.55M | 3.87% | Reduce | |
| 5 |
|
465.00K | $138.09M | 3.83% | Reduce | |
| 6 |
|
5.66M | $118.35M | 3.28% | Reduce | |
| 7 |
|
5.80M | $115.42M | 3.20% | Add | |
| 8 |
|
1.11M | $108.04M | 3.00% | Reduce | |
| 9 |
|
1.62M | $101.29M | 2.81% | Add | |
| 10 |
|
1.51M | $95.06M | 2.63% | New | |
| 11 |
|
1.32M | $76.67M | 2.12% | Add | |
| 12 |
|
4.76M | $70.93M | 1.97% | Add | |
| 13 |
|
1.90M | $69.14M | 1.92% | Add | |
| 14 |
|
44.30M | $69.11M | 1.92% | Add | |
| 15 |
|
1.71M | $65.79M | 1.82% | Add | |
| 16 |
|
2.00M | $64.97M | 1.80% | Reduce | |
| 17 |
|
3.01M | $64.95M | 1.80% | Hold | |
| 18 |
|
1.33M | $64.04M | 1.77% | Add | |
| 19 |
|
988.40K | $63.20M | 1.75% | Hold | |
| 20 |
|
725.51K | $63.10M | 1.75% | Add | |
| 21 |
|
7.69M | $55.37M | 1.53% | Hold | |
| 22 |
|
2.00M | $48.06M | 1.33% | Hold | |
| 23 |
|
1.05M | $41.84M | 1.16% | Reduce | |
| 24 |
|
818.60K | $41.29M | 1.15% | Hold | |
| 25 |
|
613.95K | $40.47M | 1.12% | New | |
| 26 |
|
2.23M | $40.41M | 1.12% | Reduce | |
| 27 |
|
8.83M | $39.47M | 1.09% | Reduce | |
| 28 |
|
1.86M | $38.80M | 1.08% | Hold | |
| 29 |
|
3.00M | $37.99M | 1.05% | Add | |
| 30 |
|
5.25M | $35.77M | 0.99% | Add | |
| 31 |
|
257.49K | $32.10M | 0.89% | Add | |
| 32 |
|
9.97M | $30.91M | 0.86% | Hold | |
| 33 |
|
746.23K | $29.25M | 0.81% | New | |
| 34 |
|
1.40M | $26.81M | 0.74% | Hold | |
| 35 |
|
1.54M | $24.18M | 0.67% | Reduce | |
| 36 |
|
900.00K | $23.31M | 0.65% | New | |
| 37 |
|
3.73M | $22.22M | 0.62% | Add | |
| 38 |
|
3.96M | $21.93M | 0.61% | New | |
| 39 |
|
1.79M | $21.32M | 0.59% | Reduce | |
| 40 |
|
641.47K | $20.07M | 0.56% | Reduce | |
| 41 |
|
65.70K | $18.89M | 0.52% | Add | |
| 42 |
|
2.35M | $18.02M | 0.50% | Add | |
| 43 |
|
2.45M | $17.76M | 0.49% | Hold | |
| 44 |
|
919.49K | $17.38M | 0.48% | New | |
| 45 |
|
1.23M | $17.10M | 0.47% | New | |
| 46 |
|
1.19M | $16.96M | 0.47% | Hold | |
| 47 |
|
8.50M | $16.57M | 0.46% | Add | |
| 48 |
|
1.00M | $16.35M | 0.45% | New | |
| 49 |
|
3.46M | $16.25M | 0.45% | New | |
| 50 |
|
89.08K | $15.54M | 0.43% | Add | |
FAQ
What did Siren, L.L.C. buy in 2026-Q1?
In its 2026-Q1 13F filing, Siren, L.L.C. reported 100 equity positions worth $3.61B in aggregate; its largest disclosed positions were SRRK ($532.16M), KYMR ($265.43M), ERAS ($181.93M).
How large is Siren, L.L.C.'s portfolio?
Siren, L.L.C. reported $3.61B of long equity holdings across 100 positions as of 2026-Q1. Top-10 holdings account for 49.8% of reported value.
What is Siren, L.L.C.'s investment style?
HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.